Mark Talamonti to Aged, 80 and over
This is a "connection" page, showing publications Mark Talamonti has written about Aged, 80 and over.
Connection Strength
0.841
-
Endovascular management of portal vein obstruction in hepatobiliary cancer patients. J Surg Oncol. 2022 Mar; 125(3):392-398.
Score: 0.091
-
Role of the HLA-C*06 allele in clinical response to ustekinumab: evidence from real life in a large cohort of European patients. Br J Dermatol. 2017 Aug; 177(2):489-496.
Score: 0.067
-
Phase II trial of full-dose gemcitabine and bevacizumab in combination with attenuated three-dimensional conformal radiotherapy in patients with localized pancreatic cancer. Int J Radiat Oncol Biol Phys. 2011 Jun 01; 80(2):476-82.
Score: 0.044
-
Quality of pancreatic cancer care at Veterans Administration compared with non-Veterans Administration hospitals. Am J Surg. 2007 Nov; 194(5):588-93.
Score: 0.035
-
Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume. Cancer. 2007 Sep 15; 110(6):1227-34.
Score: 0.034
-
Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. J Am Coll Surg. 2007 Oct; 205(4):558-63.
Score: 0.034
-
National failure to operate on early stage pancreatic cancer. Ann Surg. 2007 Aug; 246(2):173-80.
Score: 0.034
-
Preoperative chemoradiation for rectal cancer: results of multimodality management and analysis of prognostic factors. Am J Surg. 2007 Mar; 193(3):389-93; discussion 393-4.
Score: 0.033
-
Incidence of benign inflammatory disease in patients undergoing Whipple procedure for clinically suspected carcinoma: a single-institution experience. Am J Surg. 2006 Mar; 191(3):437-41.
Score: 0.031
-
A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma. Ann Surg Oncol. 2006 Feb; 13(2):150-8.
Score: 0.031
-
Preoperative evaluation of pancreatic cystic lesions: cost-benefit analysis and proposed management algorithm. Surgery. 2005 Oct; 138(4):672-9; discussion 679-80.
Score: 0.030
-
Cell free DNA in patients with pancreatic adenocarcinoma: clinicopathologic correlations. Sci Rep. 2024 07 08; 14(1):15744.
Score: 0.027
-
The minimally invasive approach confers improved outcomes in frail cancer patients undergoing hepatectomy: an American College of Surgeons National Surgical Quality Improvement Program analysis. J Gastrointest Surg. 2024 Jul; 28(7):1017-1026.
Score: 0.027
-
Merging claims databases with a tumor registry to evaluate variations in cancer mortality: results from a pilot study of 698 colorectal cancer patients treated at one hospital in the 1990s. Cancer Invest. 2004; 22(2):225-33.
Score: 0.027
-
Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. Surgery. 2003 Oct; 134(4):720-7; discussion 727-9.
Score: 0.026
-
Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis. Nat Commun. 2018 05 04; 9(1):1793.
Score: 0.018
-
Does adjuvant radiation provide any survival benefit after an R1 resections for pancreatic cancer? Surgery. 2018 05; 163(5):1047-1052.
Score: 0.018
-
Time to Initiation of Adjuvant Chemotherapy in Pancreas Cancer: A Multi-Institutional Experience. Ann Surg Oncol. 2017 Sep; 24(9):2770-2776.
Score: 0.017
-
Bioelectrical impedance analysis to define an excess of body fat: evaluation in patients with psoriasis. J Dermatolog Treat. 2017 Jun; 28(4):299-303.
Score: 0.016
-
A Multi-institutional Comparison of Perioperative Outcomes of Robotic and Open Pancreaticoduodenectomy. Ann Surg. 2016 Oct; 264(4):640-9.
Score: 0.016
-
Perioperative chemotherapy is associated with a survival advantage in early stage adenocarcinoma of the pancreatic head. Surgery. 2016 09; 160(3):714-24.
Score: 0.016
-
A Graded Evaluation of Outcomes Following Pancreaticoduodenectomy with Major Vascular Resection in Pancreatic Cancer. J Gastrointest Surg. 2016 Feb; 20(2):284-92.
Score: 0.015
-
CA 19-9 nonproduction is associated with poor survival after resection of pancreatic adenocarcinoma. Am J Clin Oncol. 2014 Dec; 37(6):550-4.
Score: 0.014
-
Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study. J Gastrointest Surg. 2013 Jan; 17(1):94-100; discussion p. 100-1.
Score: 0.012
-
Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis. Int J Radiat Oncol Biol Phys. 2011 Sep 01; 81(1):189-98.
Score: 0.011
-
The impact of methodological approaches for presenting long-term clinical data on estimates of efficacy in psoriasis illustrated by three-year treatment data on infliximab. Dermatology. 2010; 221 Suppl 1:43-7.
Score: 0.010
-
Gastrointestinal lymphoma. A case for primary surgical resection. Arch Surg. 1990 Aug; 125(8):972-6; discussion 976-7.
Score: 0.010
-
Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres. Cancer. 2009 May 01; 115(9):1849-58.
Score: 0.010
-
Methylation profile of circulating plasma DNA in patients with pancreatic cancer. J Surg Oncol. 2009 Feb 01; 99(2):119-22.
Score: 0.009
-
Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery. J Clin Oncol. 2008 Oct 01; 26(28):4626-33.
Score: 0.009
-
Sociodemographic and tumor characteristics associated with pancreatic cancer surgery in the United States. J Surg Oncol. 2008 Jun 01; 97(7):578-82.
Score: 0.009
-
Squamous cell carcinoma of the anal canal: utilization and outcomes of recommended treatment in the United States. Ann Surg Oncol. 2008 Jul; 15(7):1948-58.
Score: 0.009
-
Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial. J Clin Oncol. 2008 Feb 20; 26(6):942-7.
Score: 0.009
-
Impact of tumor location on nodal evaluation for colon cancer. Dis Colon Rectum. 2008 Feb; 51(2):154-61.
Score: 0.009
-
Extent of surgery affects survival for papillary thyroid cancer. Ann Surg. 2007 Sep; 246(3):375-81; discussion 381-4.
Score: 0.009
-
Long-term treatment of plaque psoriasis with efalizumab: an Italian experience. Br J Dermatol. 2007 Apr; 156 Suppl 2:17-23.
Score: 0.008
-
Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in carcinoid tumors. Mod Pathol. 2002 Dec; 15(12):1333-8.
Score: 0.006
-
Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery. 2001 Oct; 130(4):677-82; discussion 682-5.
Score: 0.006
-
Cystic neoplasms of the pancreas. A clinicopathologic study, including DNA flow cytometry. Arch Surg. 1995 Oct; 130(10):1048-54.
Score: 0.004